Galactomannan and Computed Tomography-Based Preemptive Antifungal Therapy in Neutropenic Patients at High Risk for Invasive Fungal Infection: A Prospective Feasibility StudyJohan Maertens, Johan Van Eldere, Koen Theunissen et al.|Clinical Infectious Diseases|2005Cited by 593
Bronchoalveolar Lavage Fluid Galactomannan for the Diagnosis of Invasive Pulmonary Aspergillosis in Patients with Hematologic DiseasesJohan Maertens, Katrien Lagrou, Koen Theunissen et al.|Clinical Infectious Diseases|2009Cited by 242
Optimization of the Cutoff Value for the Aspergillus Double-Sandwich Enzyme ImmunoassayJohan Maertens, Paul E. Verweij, Rob Klont et al.|Clinical Infectious Diseases|2007Cited by 177
Prospective clinical evaluation of lower cut‐offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipientsJohan Maertens, Johan Van Eldere, Koen Theunissen et al.|British Journal of Haematology|2004Cited by 171
Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patientsJohan Maertens, Katrien Lagrou, Kristel Buvé et al.|Cancer|2008Cited by 129